Search results for "Infusion Procedure"

showing 5 items of 5 documents

Population pharmacokinetic meta-analysis of individual data to design the first randomized efficacy trial of vancomycin in neonates and young infants.

2019

Abstract Objectives In the absence of consensus, the present meta-analysis was performed to determine an optimal dosing regimen of vancomycin for neonates. Methods A ‘meta-model’ with 4894 concentrations from 1631 neonates was built using NONMEM, and Monte Carlo simulations were performed to design an optimal intermittent infusion, aiming to reach a target AUC0–24 of 400 mg·h/L at steady-state in at least 80% of neonates. Results A two-compartment model best fitted the data. Current weight, postmenstrual age (PMA) and serum creatinine were the significant covariates for CL. After model validation, simulations showed that a loading dose (25 mg/kg) and a maintenance dose (15 mg/kg q12h if &lt…

0301 basic medicinePediatricsvancomycininfusion procedures0302 clinical medicinenewbornMedicinePharmacology (medical)Randomized Controlled Trials as Topiceducation.field_of_studyMaintenance doseAnti-Bacterial Agents3. Good healthInfectious Diseasesdrug maintenance doseResearch DesignArea Under CurveData Interpretation Statisticalcreatinine testsVancomycinMonte Carlo Methodmedicine.drugMicrobiology (medical)medicine.medical_specialty030106 microbiologyPopulationGestational AgeMicrobial Sensitivity TestsLoading doseRS03 medical and health sciencesPharmacokineticsdrug loading dose030225 pediatricsHumanssteady stateeducationPharmacologyDose-Response Relationship Drugbusiness.industryBody WeightInfant NewbornPostmenstrual AgeinfantNONMEMRegimen[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologieregimen[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologiebusinessserum
researchProduct

A first-in-human study of PDC31 (prostaglandin F2  receptor inhibitor) in primary dysmenorrhea

2014

What is the safe and pharmacodynamically active dose range for PDC31 (prostaglandin F2α receptor inhibitor) in patients with primary dysmenorrhea (PD)?The 1 mg/kg/h dose of PDC31 appears to be safe and potentially effective in reducing intrauterine pressure (IUP) and pain associated with excessive uterine contractility when given as a 3-h infusion in patients with PD.PDC31 has previously been shown to reduce the duration and strength of PGF2α-induced contractions in human uterine myometrial strip models and to delay delivery in animal models of preterm labor.This was a prospective, multi-center, dose-escalating first-in-human Phase I study conducted from March 2011 to June 2012. A total of …

AdultVisual analogue scaleUterusPlaceboDrug Administration ScheduleUterine contractionYoung AdultDysmenorrheaPharmacokineticsInfusion ProceduremedicineHumansProspective StudiesAdverse effectDose-Response Relationship Drugbusiness.industryRehabilitationObstetrics and GynecologyTreatment Outcomemedicine.anatomical_structureReproductive MedicineAnesthesiaPharmacodynamicsFemalemedicine.symptomPeptidesbusinessHuman Reproduction
researchProduct

Cerebrospinal fluid pharmacokinetics of ceftaroline in neurosurgical patients with an external ventricular drain

2019

IF 5.217; International audience; BackgroundOwing to its antibacterial properties, ceftaroline could be attractive for prevention or treatment of bacterial post-neurosurgical meningitis/ventriculitis. However, few data are available concerning its meningeal concentrations.ObjectivesTo investigate ceftaroline CSF pharmacokinetics in ICU patients with an external ventricular drain (EVD).MethodsPatients received a single 600 mg dose of ceftaroline as a 1 h intravenous infusion. Blood and CSF samples were collected before and 0.5, 1, 3, 6, 12 and 24 h after the end of the infusion. Concentrations were assayed in plasma and CSF by LC–MS/MS. A two-step compartmental pharmacokinetic analysis was c…

Male0301 basic medicinemedicine.medical_treatmentprotein bindinginfusion proceduresintensive care unitCerebral VentriclesCerebral VentriculitisPostoperative Complications0302 clinical medicineCerebrospinal fluidTandem Mass SpectrometryPharmacology (medical)030212 general & internal medicineInfusions Intravenousintravenous infusion proceduresmeningitisMiddle AgedAnti-Bacterial Agents3. Good healthIntensive Care UnitsInfectious DiseasesAnesthesiaDrainageceftarolineFemalepharmacokineticsMeningitisAdultMicrobiology (medical)VentriculostomyAdolescent030106 microbiologyCmax[SDV.MHEP.CHI]Life Sciences [q-bio]/Human health and pathology/Surgerycerebrospinal fluidMeningitis BacterialYoung Adult03 medical and health sciencesPharmacokineticsavian ventriculitismedicineVentriculitisHumansDistribution (pharmacology)plasmaAgedbacterial post-neurosurgical meningitis/ventriculitisPharmacologybusiness.industryModels Theoreticalmedicine.diseaseneurosurgical proceduresCephalosporinsventriculostomybusinessChromatography LiquidExternal ventricular drainJournal of Antimicrobial Chemotherapy
researchProduct

Vitamin A in parenteral nutrition: uptake and distribution of retinyl esters after intravenous application.

1989

Short-term parenteral application of vitamin A was examined in rats. Retinyl margarinate, which is chemically similar to physiological retinyl esters, was used in vitamin A-depleted rats to study uptake, distribution, and storage of retinyl esters in tissues. Vitamin A-depleted and Vitamin A-sufficient rats were infused with a micellar suspension of retinyl margarinate for 7 h and then killed at different times. Retinyl margarinate was directly taken up by all tissues examined. It appears that infusion of retinyl esters in micellar form provides a direct way to supply vitamin A to peripheral, vitamin A-dependent tissues. Therefore, a short-term infusion of retinyl esters with an emulsifier …

VitaminMalemedicine.medical_specialtyRetinyl EstersMedicine (miscellaneous)Retinyl esterschemistry.chemical_compoundPharmacokineticsInfusion ProcedureInternal medicineTestismedicineDistribution (pharmacology)AnimalsTissue DistributionIntestinal MucosaVitamin ALungChromatography High Pressure LiquidChromatographyNutrition and Dieteticsbusiness.industryVitamin A DeficiencyRetinolMetabolismRatsTracheaEndocrinologyParenteral nutritionchemistryLiverParenteral Nutrition TotalDiterpenesbusinessSpleenThe American journal of clinical nutrition
researchProduct

P255 Efficacy and safety of a restrictive ferric carboxymaltose infusion strategy for iron deficiency anemia in inflammatory bowel disease patients

2021

Abstract Background Iron deficiency anemia (IDA) is a common condition in patients with inflammatory bowel disease (IBD) and ferric carboxymaltose (FCM) has shown fast correction of hemoglobin (Hb) levels and good tolerability. We evaluated the response to FCM in IBD patients with IDA. The primary outcome was the assessment of the rate of response to single or multiple FCM infusions after 12 months from the first infusion. Secondary outcomes were the response to a single FCM infusion after 3 months and the assessment of FCM safety. Methods We retrospectively included 185 consecutive patients from IBD Unit of “Villa Sofia-V. Cervello” Hospital who received at least a dose of 500 mg FCM infus…

medicine.medical_specialtyUnivariate analysisbusiness.industryAnemiaGastroenterologyGeneral Medicinemedicine.diseaseInflammatory bowel diseaseGastroenterologyFERRIC CARBOXYMALTOSEIron-deficiency anemiaInternal medicineInfusion ProceduremedicineHemoglobinbusinessAdverse effectJournal of Crohn's and Colitis
researchProduct